Syneron Medical Ltd. develops, markets and sells elos combined-energy medical aesthetic devices. At last week’s American Academy of Dermatology 67th Annual Meeting in San Francisco Syneron introduced eMatrix skin resurfacing device for darker skin types. It is the only fractional device capable of safely treating patients with skin of color (skin types V and VI on the Fitzpatrick skin classification scale). The eMatrix opens the in-demand fractional ablative treatment market to a larger patient base.

Named first prize winner in the device category for its industrial design by the Israel Ministry of Industry, Trade & Labor, the stylish and functional eMatrix utilizes Matrix RF technology, the world’s first RF-only fractional technology for ablation and skin resurfacing. Clinical studies currently in process using eMatrix’s Matrix RF technology reveal the unique ability to treat skin of color due to the RF-based energy applied to the skin. Launched in December 2008, results of Matrix RF treatments with the eMatrix device include skin rejuvenation, wrinkle reduction and skin tightening.

Fractional treatments are one of the fastest-growing areas of aesthetic procedures. In 2008 alone, the volume of fractional skin rejuvenation procedures was estimated to have grown 200 percent from 2007, according to a May 2008 study by Medical Insights. By 2010, the number of treatments is anticipated to double the number of procedures carried out in 2008.

Since we do provide in-depth coverage for non-laser technologies, we published the news about eMatrix fractional ablative RF device to help our readers form a better and more complete understanding of the current aesthetic market trends.